Arcutis Biotherapeutics I...

NASDAQ: ARQT · Real-Time Price · USD
16.91
0.93 (5.82%)
At close: Aug 15, 2025, 3:59 PM
16.61
-1.75%
After-hours: Aug 15, 2025, 07:30 PM EDT

Arcutis Biotherapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-15.89M -25.06M -10.79M -41.54M -52.33M -35.38M -66.28M -44.77M -70.99M -80.1M -72.02M -107.71M -67.41M -64.32M -71.33M -56.98M -42.01M -36.04M
Depreciation & Amortization
410K 3.13M 458K 1.43M 351K 358K 385K 387K 386K 363K 347K 282K 155K 150K 136K 116K 104K 98K
Stock-Based Compensation
10.49M 9.78M 9.39M 9.78M 12.52M 10.03M 8.76M 10M 10.58M 9.48M 9.26M 8.79M 8.1M 6.53M 5.69M 5.36M 4.34M 8.5M
Other Working Capital
3.7M -3.7M 12.93M 19.2M 6.71M 5.03M 7.21M 443K -4.31M -7.03M 1.64M 7.75M 458K -5.62M 10.44M 7.15M 1.36M -15.58M
Other Non-Cash Items
-12.38M -543K 1.76M -14.08M 22.8M 20.05M 16.82M 1.11M 1.09M -1.08M -1.24M 29.71M 747K 1.09M 75K 76K 78K 80K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -16.33M -1.53M -1.82M n/a n/a n/a n/a n/a 885K 1.15M 799K 616K
Change in Working Capital
17.69M -17.69M -1.57M 9.71M -4.27M -5.44M 411K -9.18M -5.73M -9.01M -7.41M 1.23M -3.57M -423K 12.84M 9.39M 856K -19.46M
Operating Cash Flow
324K -30.38M -748K -34.69M -45.12M -31.6M -56.24M -43.98M -66.48M -80.34M -71.06M -67.69M -61.98M -56.98M -51.71M -40.88M -35.83M -46.2M
Capital Expenditures
-78K -608K -5M -143K n/a n/a -6K -64K -276K -82K -123K -22.96M -80K -124K -261K -137K -43K -554K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a 62.18M -45.61M -89.39M -107.83M 22.95M 15.45M -52.65M n/a n/a n/a n/a n/a
Purchase of Investments
-33.15M -56.11M -17.4M -5.69M -125.78M -105.95M -118.18M -22.39M -45.61M -39.67M -38.09M -241.56M -80.24M -55.5M -48.24M -32.39M -211.88M n/a
Sales Maturities Of Investments
60.65M 68.47M 57.28M 90.61M 63.64M 77.25M 56M 68M 135M 147.5M 80.41M 67.25M 132.89M 70.92M 72M 36M 47M 62.55M
Other Investing Acitivies
-10M n/a n/a n/a -62.14M -28.7M -62.18M 45.61M 89.39M 107.83M -22.95M -15.45M 52.65M 15.42M 23.76M 3.61M -164.88M 62.55M
Investing Cash Flow
17.42M 11.75M 34.88M 84.78M -62.14M -28.7M -62.19M 45.55M 89.12M 107.75M 42.2M -197.26M 52.56M 15.3M 23.5M 3.47M -164.92M 62M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
1.32M n/a n/a 649K n/a n/a n/a n/a n/a n/a 12.47M n/a n/a n/a 842K n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
61K 395K -97.41M 394K 1.46M 82K 388K 867K 1.07M 100K 962K 123.4M 1.13M 261K 72.88M 63K 1.19M 325K
Financial Cash Flow
1.38M 395K -97.41M 394K 1.46M 161.76M 99.29M 867K 1.07M 100K 962K 284.99M 1.13M 14.72M 72.88M 63K 1.19M 207.81M
Net Cash Flow
19.33M -18.23M -63.52M 50.58M -105.83M 101.39M -19.07M 2.36M 23.71M 27.45M -27.9M 20.03M -8.28M -26.96M 44.67M -37.35M -199.56M 223.61M
Free Cash Flow
246K -30.99M -5.75M -34.83M -45.12M -31.6M -56.25M -44.05M -66.76M -80.43M -71.19M -90.65M -62.06M -57.1M -51.97M -41.02M -35.87M -46.76M